Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janka Kovács

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Cells|July 30, 2020
Opposing Roles of S1P<sub>3</sub> Receptors in Myocardial FunctionDina Wafa, Nóra Koch, Janka Kovács, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 1, 2025
A Nonparametric Population Pharmacokinetic Model of Selumetinib in Pediatric Patients Diagnosed With Neurofibromatosis-I or Plexiform NeurofibromasZoltán Köllő, Janka Kovács, Michael N Neely, et al.
Pediatric Blood & Cancer|April 20, 2026
Personalized Selumetinib Dosing in Pediatric Neurofibromatosis Type 1: Insights From a Pilot Therapeutic Drug Monitoring StudyJanka Kovács, Zoltán Köllő, Balázs Gellért Karvaly, et al.
Plos One|February 20, 2025
Proton or photon? Comparison of survival and toxicity of two radiotherapy modalities among pediatric brain cancer patients: A systematic review and meta-analysisRenáta Kiss-Miki, Mahmoud Obeidat, Vanda Máté, et al.
Neurosurgery|May 29, 2024
Antibiotic-Impregnated Ventriculoperitoneal Shunts Decrease Bacterial Shunt Infection: A Systematic Review and Meta-AnalysisJanka Kovács, Vanda Máté, Mahmoud Obeidat, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Cells|July 30, 2020
Opposing Roles of S1P<sub>3</sub> Receptors in Myocardial FunctionDina Wafa, Nóra Koch, Janka Kovács, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 1, 2025
A Nonparametric Population Pharmacokinetic Model of Selumetinib in Pediatric Patients Diagnosed With Neurofibromatosis-I or Plexiform NeurofibromasZoltán Köllő, Janka Kovács, Michael N Neely, et al.
Pediatric Blood & Cancer|April 20, 2026
Personalized Selumetinib Dosing in Pediatric Neurofibromatosis Type 1: Insights From a Pilot Therapeutic Drug Monitoring StudyJanka Kovács, Zoltán Köllő, Balázs Gellért Karvaly, et al.
Plos One|February 20, 2025
Proton or photon? Comparison of survival and toxicity of two radiotherapy modalities among pediatric brain cancer patients: A systematic review and meta-analysisRenáta Kiss-Miki, Mahmoud Obeidat, Vanda Máté, et al.
Neurosurgery|May 29, 2024
Antibiotic-Impregnated Ventriculoperitoneal Shunts Decrease Bacterial Shunt Infection: A Systematic Review and Meta-AnalysisJanka Kovács, Vanda Máté, Mahmoud Obeidat, et al.
Pageof 1